Implementation of a Rapid Diagnostic Test for Infections
Study Overview
This study evaluated a new blood test, MeMed BV® (MMBV), which can tell if an infection is bacterial or viral. The test was used in ten urgent care centers (UCCs) from April 2022 to March 2023. The main goal was to see how the test affected antibiotic use, and the secondary goal was to see how it helped doctors manage patients.
Study Methods
We conducted a pragmatic study with real-time reports from 144 physicians who ordered the MMBV test. They noted if they planned to prescribe antibiotics before the test and whether the test helped them after assessing the patient.
Key Results
- 3920 MMBV tests were ordered for adults.
- 19.3% of cases showed unnecessary antibiotic prescriptions, with doctors avoiding prescriptions in 63.1% of these cases.
- 12.4% of cases had potentially missed bacterial infections, with 69.9% receiving antibiotic treatment.
- Using MMBV was linked to fewer hospitalizations (7.8% vs. 30.3%).
- Doctors reported that MMBV helped in managing patients in 86.0% of cases and avoided emergency referrals in 20.5% of cases.
Conclusion
Introducing MMBV in urgent care centers improved doctors’ decision-making, led to better antibiotic use, and enhanced patient management.
Enhancing Clinical Practice with Technology
Clinical trials are essential for ensuring safe treatments. Our AI platform, DocSym, combines ICD-11 standards and clinical protocols for easy access by healthcare professionals.
Improving Patient Care
In today’s fast-paced healthcare environment, our mobile apps help streamline operations, scheduling, treatment monitoring, and telemedicine, making patient care more efficient.
Embracing AI for Better Outcomes
By integrating AI, clinics can improve workflows, enhance patient outcomes, and reduce paperwork. Discover how we can assist you at aidevmd.com.